Línies de recerca

  • Non-invasive, imaging-based assessment of atrial fibrillation pathology

    The non-invasive identification of atrial fibrillation pathology drivers has the potential to remarkably improve atrial fibrillation prevention, early diagnosis and treatment. Atrial fibrosis is a hallmark of the atrial fibrillation pathology. In this regard, we have reported a novel standardized, reproducible method to delimitate atrial fibrosis by mean of late-gadolinium-enhanced magnetic resonance imaging. We are currently working in the atrial characterization of atrial fibrillation patients to uncover how can it help in therapy personalization and ablation tailoring.

  • Improvement of atrial fibrillation therapy

    The therapeutic strategies in atrial fibrillation remain suboptimal due to frequent arrhythmia recurrences and complications, including stroke and heart failure. We aim at improving the care of atrial fibrillation patients to improve quality of life and reduce complications burden. At our center, we have designed and conducted randomized clinical trials to determine the best ablation technique for each patient based on their characteristics. The benefits of integrated care are currently being tested. We moreover participate in multicenter studies testing different therapeutic approaches, ablation techniques and novel drugs.

  • Etiological factors of atrial fibrillation

    Our group focuses in the study of the etiologic factors of atrial fibrillation to understand its mechanisms and prevent its development. We are currently assessing the association of the sympathetic/parasympathetic balance to analyze the relationship between stature and autonomic balance